Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Stock Breaks Out on Strong Q2 Earnings

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen Inc.'s (AMGN) stock has been on an upward trend after the company reported second-quarter adjusted EPS of $6.29 and revenue of $10.1 billion, surpassing market expectations.

The stock's price is currently holding above its key moving averages, with firm intraday momentum, and has even surpassed the session high.

Amgen raised its full-year 2026 revenue outlook and increased its quarterly dividend by 6%, driving investor optimism.

The company also reported a 10% year-over-year product sales growth across its extensive portfolio, while advancing its MariTide obesity treatment program with multiple Phase 3 trials.

More on Stocks

Stocks just now

Western Union Unveils Stablecard for Cross-Border Spending

Stocks just now

Nike's Opening Event: Where Athletes Find More Than Just a Platform

Stocks 1m ago

Nvidia Open-Sources CuFile Storage Stack, Sets Industry Standard for GPU Storage

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy